Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Behav Pharmacol. 2012 Jun;23(3):271–279. doi: 10.1097/FBP.0b013e3283536d6f

Table 1.

Representative Study Schedule

MON TUES WED THURS FRI
DOSING PHASE Intermittent Intermittent Intermittent Intermittent Intermittent
PHASE DAY 1 2 3 4 5
OXY DOSE 0, 5, 20 mg/70 kg 0 mg BID 0 mg BID 0 mg BID 0, 5, 20 mg/70 kg
DOSING PHASE Daily Daily Daily Daily Daily
PHASE DAY 1 2 3 4 5
OXY DOSE 0, 5, 20 mg/70 kg 15 mg BID 15 mg BID 15 mg BID 0, 5, 20 mg/70 kg